COMMUNIQUÉS West-GlobeNewswire
-
RAMSAY GENERALE DE SANTE : AMENDEMENT ET EXTENSION DE LA CONVENTION DE CREDIT SENIOR
11/08/2017 - 17:35 -
RAMSAY GENERALE DE SANTE : AMEND AND EXTEND OF ITS SENIOR FACILITIES AGREEMENT
11/08/2017 - 17:35 -
ProMIS Neurosciences Announces Second Quarter 2017 Results
11/08/2017 - 13:30 -
PCI Biotech: First patient dosed in the fimaCHEM Phase I extension study
11/08/2017 - 08:00 -
Notice of Nexstim Plc's Half-Yearly Report H1 2017
11/08/2017 - 08:00 -
ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
11/08/2017 - 07:17 -
ABLYNX ANNOUNCES WARRANT EXERCISE
11/08/2017 - 07:00 -
EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017
10/08/2017 - 22:30 -
Reviewed Financial Statement's announcement for the period 30 June 2017
10/08/2017 - 17:50 -
Ossur Hf : Insider Trading
10/08/2017 - 16:50 -
Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2017
10/08/2017 - 15:37 -
Zealand Pharma A/S publishes prospectus
10/08/2017 - 14:07 -
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
10/08/2017 - 14:02 -
RedHill Biopharma Provides 2017 Semi-Annual Business Update
10/08/2017 - 14:00 -
Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
10/08/2017 - 12:30 -
Présentation de Merus à la Wedbush PacGrow Healthcare Conference 2017
10/08/2017 - 09:55 -
Active Biotech AB - Interim report January - June 2017
10/08/2017 - 08:30 -
Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
10/08/2017 - 08:00 -
Basilea reports improved financial results in half-year 2017 driven by growing product sales; significant progress on partnering and development programs
10/08/2017 - 07:15
Pages